We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: A new test relies on highly specific biomarkers to diagnose preeclampsia (Photo courtesy of Pexels)

Rapid POC Test for Diagnosis of Preeclampsia Could Prevent Unnecessary Hospitalization

A fast and precise point-of-care test for preeclampsia is being developed that would provide diagnostic certainty and at the same time, save healthcare costs. More...
16 May 2022
Image: VIDAS Anti-CHIKUNGUNYA IgM and Anti-CHIKUNGUNYA IgG (Photo courtesy of bioMérieux)

BioMérieux’s New Automated Tests for Chikungunya Virus Diagnosis Offer Better Traceability

Newly-launched tests for the diagnosis of Chikungunya virus infection aim to help improve access to medically important automated diagnostic tests in low- and middle-income countries. More...
16 May 2022
Image: Lab-on-a-chip technology enables rapid testing for various human ailments (Photo courtesy of University of Kansas)

Lab-on-a-Chip Technology Detects Hard-to-Diagnose Diseases

A new technology takes small plastic chips made of the same material as a compact disc or DVD, then transforms them into marvels of engineering and chemistry that quickly can detect hard-to-diagnose human diseases using saliva, urine or blood from a patient. More...
13 May 2022
Image: Multiplo Complete Syphilis (TP/nTP) Antibody Test has received CE Mark (Photo courtesy of MedMira Inc.)

Syphilis Antibody Assay Combines Screening and Confirmation in One POC Test

Syphilis is a sexually transmitted disease that has a tremendous impact on global health. Now, the only commercially available combined screening and confirmation test for syphilis takes less than three minutes (from sample collection to easy-to-read results) for diagnosis at POC. More...
13 May 2022
Image: Nonagen’s Oncuria bladder cancer diagnostic panel uses xMAP Luminex technology (Photo courtesy of Pexels)

First-of-Its-Kind Multiplex Protein-Based Urine Test Detects Bladder Cancer

A first-of-its-kind multiplex protein-based urine test that provides early and accurate detection, therapy choice, and disease monitoring of bladder cancer can help improve patient outcomes. More...
13 May 2022
Image: OvaCis rapid test is slated to launch in EU and Southeast Asia by 2022 end (Photo courtesy of INEX Innovate)

Rapid Ovarian Cancer Test Cuts Surgical Procedure Time and Infection Risk

A first of its kind point-of-care (POCT) test discriminates benign from malignant ovarian cysts in an operating theater setting and significantly reduces surgical procedure time by providing results in 15 minutes. More...
12 May 2022
Image: Aptima CMV Quant Assay for human cytomegalovirus has received FDA approval (Photo courtesy of Hologic)

Quantitative Test for Post-Transplant Pathogen Detection Improves Patient Outcomes

A new assay to quantify the viral load of cytomegalovirus (CMV) in patients who have had solid organ or stem cell transplants can support patient care following transplant surgery. More...
12 May 2022
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
Rapid Molecular Testing Device
FlashDetect Flash10
Human Estradiol Assay
Human Estradiol CLIA Kit


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
GLOBE SCIENTIFIC, LLC